Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Primary or Recurrent CDI
NCT03053505Unknown
- Sponsor
- Sejtterapia Kozpont
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of allogeneic fecal microbiota in Clostridioides difficile infection (CDI) (3 arms), sponsored by Sejtterapia Kozpont. Primary endpoints: Global cure rate at 10 weeks, Time to clinical cure at 18 months and 5 more. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT03053505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03053505.